Trial intelligence / Profile preview

Side effects of intrathecal morphine in orthopedic surgery

PACTR202303901133915Phase 3Not yet recruiting

Sponsor
Dr. Mona Raafat Elghamry
Start
May 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, single-arm trial of morphine, sponsored by Dr. Mona Raafat Elghamry. Primary endpoints: Nausea, Pruritus and 1 more. Planned start May 2023; status: not yet recruiting.

02

Drugs

morphine

Beyond the preview

Go deeper on PACTR202303901133915.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202303901133915.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call